Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesExcluding deep venous thrombosis in symptomatic outpatients: is fibrin monomer aid to D-dimer analysis
Blood Coagulation & Fibrinolysis, 10/07/09
Dopsaj V et al. – Simultaneous D–dimer and fibrin monomer determination provides a more valuable approximation for DVT exclusion compared with just D–dimer analysis. Bearing in mind that the fibrin monomer assay is now both more practical and more suited for routine clinical use, fibrin monomer determination could be a more commonly used parameter together with D–dimer and pretest probability score for DVT diagnosis in the future.
Related Articles
Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism
Chest, 10/08/09
Relevance Score: 90%
Hematocrit and risk of venous thromboembolism in a general population. The Tromso Study
Haematologica, 10/21/09
Relevance Score: 89%
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER)
Annals of Oncology, 10/20/09
Relevance Score: 89%
Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy
Blood Coagulation & Fibrinolysis, 10/07/09
Relevance Score: 89%
Use of deep vein thrombosis prophylaxis in hospitalized cancer patients
Blood Coagulation & Fibrinolysis, 10/07/09
Relevance Score: 89%
Today in Coagulation/Bleeding Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
An open clinical study assessing the efficacy and safety of Factor IX Grifols, a high-purity Factor IX concentrate, in patients with severe haemophilia B
Haemophilia, 12/16/09
Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia A
Haemophilia, 12/16/09
Particulate Air Pollution and Cardiovascular Risk: Short-term and Long-term Effects
Seminars in Thrombosis and Hemostasis, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor